Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation.
Mehra
M R
MR
The Ochsner Cardiomyopathy and Heart Transplantation Center, Ochsner Medical Institutions, New Orleans, Louisiana, USA. mmehra@ochsner.org
Uber
P A
PA
Scott
R L
RL
Prasad
A K
AK
Park
M H
MH
D044383:Black People; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000235:genetics / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D011446:Prospective Studies; D016019:Survival Analysis; D016559:Tacrolimus / Q000627:therapeutic use*; D016896:Treatment Outcome; D044465:White People
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D016559:Tacrolimus